**Title of Invention:** A System and Method for AI-Powered Personalized Drug Dosage Calculation

**Abstract:**
A system is disclosed for assisting clinicians in determining optimal drug dosages by leveraging advanced artificial intelligence. The system securely ingests a comprehensive suite of patient medical data, including but not limited to electronic health records, anthropometric measurements like weight and age, detailed kidney and liver function tests, genetic markers, and real-time physiological data from wearables. This multifaceted data is then provided to a sophisticated generative AI model, further augmented by specialized pharmacokinetic/pharmacodynamic PK_PD models, all trained on an extensive corpus of pharmacological research, clinical trial results, and real-world patient outcomes. The AI computes a personalized, optimal dosage for a specified medication, simultaneously generating a precise confidence interval, a detailed, evidence-based rationale, and flagging potential drug-drug interactions or contraindications, thereby accounting for the patient's unique metabolic profile and overall health status.

**Detailed Description:**
Imagine a doctor needing to prescribe a sensitive medication to a patient with mild kidney impairment and several co-morbidities. They access the system and input the patient's identifier and the drug name. The system then automatically retrieves relevant patient data, or the doctor can manually add specific details. A prompt is generated for the specialized medical AI: `Calculate the optimal starting dose of [Drug X] for a 75kg, 60-year-old male with a creatinine clearance of 55 mL/min, also considering his known CYP2D6 slow metabolizer status and concurrent medication Y.` The AI, leveraging its internal knowledge base, pharmacokinetic_pharmacodynamic models, and machine learning algorithms, processes this complex input. It might respond: `Recommended starting dose: 7.5mg (standard is 10mg). Confidence Level: High 92%. Rationale: The 25% dose reduction is advised to account for the decreased renal clearance and the CYP2D6 slow metabolizer status, minimizing the risk of toxic accumulation and adverse events. No significant drug-drug interactions detected with concurrent medication Y, but monitor for increased sedation.` This detailed output allows the clinician to make an informed, patient-specific prescribing decision.

**System Architecture and Workflow:**

The following diagram illustrates the comprehensive workflow and architectural components of the AI-powered personalized drug dosage system. It emphasizes data ingestion, AI processing, validation, and clinician interaction.

```mermaid
graph TD
    subgraph Input and Data Acquisition
        A[Clinician Input Request Drug Dosage] --> B[System Interface]
        B --> C[Patient Identifier]
        C --> D[Electronic Health Record EHR System]
        D --> E[Laboratory Information System LIS]
        D --> F[Genomic Data Repository]
        D --> G[Wearable Device Data Stream]
        E --> H[Medical Imaging System Optional]
    end

    subgraph Data Ingestion and Preprocessing
        D -- Patient Demographics Clinical History --> I[Data Ingestion Module]
        E -- Renal Hepatic Functions Metabolite Levels --> I
        F -- Genetic Markers Drug Metabolism Genes --> I
        G -- Realtime Biometrics Activity Sleep --> I
        H -- Anatomical Data Organ Size --> I
        I --> J[Data Harmonization and Feature Engineering]
        J --> K[Data Validation and Anomaly Detection]
    end

    subgraph AI Core Processing Engine
        K --> L[Generative AI Model LLM for Rationale]
        K --> M[Pharmacokinetic_Pharmacodynamic PKPD Models]
        K --> N[Machine Learning Algorithms for Risk Prediction]
        L -- Contextual Understanding Natural Language --> P[Dosage Calculation Engine]
        M -- Drug Specific Models Patient Parameters --> P
        N -- Adverse Event Risk Interaction Prediction --> P
        P --> Q[Personalized Dosage Recommendation]
    end

    subgraph Output Generation and Validation
        Q --> R[Confidence Interval Calculation]
        Q --> S[Evidence Based Rationale Generation]
        Q --> T[Drug Drug Interaction Checker]
        Q --> U[Allergy Contraindication Alert System]
        R --> V[Output Presentation Layer]
        S --> V
        T --> V
        U --> V
    end

    subgraph Clinician Review and Action
        V --> W[Clinician Review Approval Modification]
        W -- Approved Dose --> X[Prescription Generation Module]
        W -- Feedback for AI Model --> Y[Continuous Learning Feedback Loop]
        X --> Z[Pharmacy Information System Integration]
        Z --> AA[Medication Dispensation to Patient]
        AA --> BB[Post Prescription Monitoring Optional]
        BB --> J
        Y --> L
        Y --> M
        Y --> N
```

**Claims:**
1.  A method for determining a personalized drug dosage for a patient, comprising:
    a.  Receiving diverse patient-specific medical data, including at least two of the following: anthropometric data, electronic health record data, laboratory test results, genomic markers, and real-time physiological data from wearable devices.
    b.  Performing data harmonization and validation on the received medical data.
    c.  Providing the harmonized data to a multi-component artificial intelligence framework comprising:
        i.  A generative AI model configured to understand clinical context and generate human-readable rationales.
        ii. Specialized pharmacokinetic_pharmacodynamic PKPD models.
        iii. Machine learning algorithms trained for risk prediction and pattern recognition.
    d.  Prompting the AI framework to calculate a personalized drug dosage for a specified medication, taking into account the patient's unique metabolic profile, genetic predispositions, and co-existing conditions.
    e.  Generating a confidence interval for the recommended dosage.
    f.  Generating an evidence-based rationale explaining the dosage recommendation.
    g.  Performing automated checks for potential drug-drug interactions and known allergies or contraindications based on the patient's profile.
    h.  Displaying the recommended dosage, confidence interval, detailed rationale, and any relevant warnings to a qualified medical professional via a graphical user interface.

2.  The method of Claim 1, further comprising:
    a.  Receiving clinician feedback on the recommended dosage, rationale, or warnings.
    b.  Utilizing the clinician feedback to refine and improve the AI framework through a continuous learning feedback loop.

3.  The method of Claim 1, further comprising:
    a.  Integrating the system with an existing Electronic Health Record EHR system for automated data retrieval and prescription generation.
    b.  Integrating with a Pharmacy Information System for seamless transmission of approved prescriptions.

4.  A system for personalized drug dosage calculation, comprising:
    a.  A Data Ingestion Module configured to retrieve and process patient medical data from multiple sources including EHR systems, laboratory systems, genomic repositories, and wearable devices.
    b.  A Data Harmonization and Validation Unit configured to prepare patient data for AI processing.
    c.  An AI Core Processing Engine comprising:
        i.  A Generative AI Model for contextual understanding and rationale creation.
        ii. A suite of Pharmacokinetic_Pharmacodynamic PKPD Models.
        iii. Machine Learning Algorithms for risk assessment.
    d.  A Dosage Calculation Engine to determine personalized drug dosages.
    e.  An Output Generation and Validation Unit, including a Confidence Interval Calculator, a Rationale Generator, and modules for Drug Drug Interaction and Allergy Contraindication checking.
    f.  A Clinician Interface for presenting recommendations, warnings, and receiving clinician input and approval.
    g.  A Continuous Learning Feedback Loop connected to the AI Core Processing Engine.

5.  The system of Claim 4, further comprising:
    a.  Modules for integration with external healthcare systems such as EHR, LIS, and Pharmacy Information Systems.
    b.  A Post Prescription Monitoring Optional module to track patient outcomes and feed data back into the system for refinement.